PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930118
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930118
The global robotic surgical procedures market has emerged as one of the fastest-growing segments within advanced medical technologies, driven by the increasing adoption of minimally invasive surgeries and continuous innovation in surgical robotics. According to Fortune Business Insights, the market was valued at USD 13.32 billion in 2025 and is projected to expand significantly to USD 15.9 billion in 2026, reaching USD 54.61 billion by 2034, registering a robust CAGR of 16.68% during 2026-2034.
Market Overview
Robotic surgery, also referred to as robot-assisted surgery, enables surgeons to perform complex procedures with enhanced precision, flexibility, and control. These procedures are widely used in general surgery, gynecology, urology, orthopedics, and other specialties. The growing preference for minimally invasive techniques, reduced hospital stays, faster recovery times, and improved clinical outcomes are major factors accelerating the adoption of robotic surgical procedures globally.
Despite a sharp decline of -14.3% in 2020 due to the COVID-19 pandemic, the market has shown a strong recovery trajectory. The cancellation and postponement of elective surgeries during the pandemic temporarily reduced demand; however, the resumption of surgical volumes has restored growth to pre-pandemic levels.
Impact of COVID-19
The COVID-19 pandemic negatively impacted the robotic surgical procedures market due to widespread cancellation of elective surgeries. According to the CovidSurg Collaborative, approximately 28 million elective surgeries were cancelled or postponed globally during peak disruption. Additionally, leading players such as Intuitive Surgical reported a revenue decline of around -6.0% in the first half of 2020, mainly due to reduced procedure volumes and supply chain disruptions. Nevertheless, post-pandemic recovery has significantly strengthened market demand.
Market Size and Key Highlights
In terms of regional dominance, North America accounted for 73.89% of the global market share in 2025, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of robotic systems.
Driving Factors
The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and orthopedic conditions is a key driver of market growth. For instance, prostate cancer cases are expected to increase steadily, leading to higher volumes of robot-assisted prostatectomy procedures. Additionally, the growing geriatric population and sedentary lifestyles are further contributing to the increased demand for surgical interventions.
Technological advancements also play a critical role. Leading companies are continuously introducing next-generation robotic systems. For example, Intuitive Surgical's FDA-approved da Vinci SP system has enabled single-port access for complex urological procedures, significantly enhancing surgical efficiency.
Market Restraints
Despite strong growth potential, the market faces challenges related to high acquisition and maintenance costs of robotic surgical systems. Annual maintenance costs for systems such as the da Vinci robot range between USD 100,000 and USD 150,000, while robotic procedures can cost USD 3,000-6,000 more than conventional laparoscopic surgeries. These cost barriers limit adoption, particularly in emerging economies.
By application, general surgery dominated the market, holding a 32.02% share in 2026, supported by the high volume of procedures such as hysterectomy, nephrectomy, and cardiac valve repair. Orthopedics is expected to grow at a higher CAGR due to increasing orthopedic disorders and the introduction of specialized robotic platforms. Urology and gynecology are also projected to witness strong growth during the forecast period.
Competitive Landscape
The market is largely dominated by Intuitive Surgical, owing to its strong product portfolio and global presence. Other key players include Stryker, Medtronic, Johnson & Johnson Services, Smith & Nephew, Zimmer Biomet, and CMR Surgical. Strategic acquisitions and partnerships remain a key trend, such as Medtronic's acquisition of Digital Surgery in 2020 to strengthen AI-driven robotic platforms.
Conclusion
In conclusion, the global robotic surgical procedures market is set for exceptional growth from USD 13.32 billion in 2025 to USD 54.61 billion by 2034, fueled by rising chronic disease prevalence, technological innovation, and increasing adoption of minimally invasive surgeries. Although high system costs remain a challenge, expanding reimbursement policies and continuous product advancements are expected to sustain strong market momentum throughout the forecast period.
Segmentation
By Application
By Geography